David A. Giljohann
Chief Executive Officer chez EVOQ Therapeutics, Inc.
Profil
David A.
Giljohann is currently the Chief Executive Officer at EVOQ Therapeutics, Inc. He previously worked as the Chief Technology Officer at Exicure, Inc. from 2021 to 2022.
Prior to that, he was the Chief Operating Officer & Principal Scientist at Exicure Operating Co. from 2012 to 2013.
He also worked as a Founding Scientist at Aurasense LLC.
Dr. Giljohann received his undergraduate and doctorate degrees from Northwestern University.
Postes actifs de David A. Giljohann
| Sociétés | Poste | Début |
|---|---|---|
EVOQ Therapeutics, Inc.
 EVOQ Therapeutics, Inc. BiotechnologyHealth Technology EVOQ Therapeutics LLC operates as a biopharmaceutical company, which engages in developing new vaccine technologies for improving outcomes for cancer patients. The company was founded by William Brinkerhoff, James Moon, and Anna Schwendeman in 2016 and is headquartered in Ann Arbor, MI. | Chief Executive Officer | 09/01/2023 |
Anciens postes connus de David A. Giljohann
| Sociétés | Poste | Fin |
|---|---|---|
| EXICURE, INC. | Chief Executive Officer | 10/12/2021 |
| Aurasense LLC | Chief Tech/Sci/R&D Officer | 01/01/2009 |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Chief Executive Officer | - |
Formation de David A. Giljohann
| Northwestern University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EXICURE, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Aurasense LLC | |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Health Technology |
EVOQ Therapeutics, Inc.
EVOQ Therapeutics, Inc. BiotechnologyHealth Technology EVOQ Therapeutics LLC operates as a biopharmaceutical company, which engages in developing new vaccine technologies for improving outcomes for cancer patients. The company was founded by William Brinkerhoff, James Moon, and Anna Schwendeman in 2016 and is headquartered in Ann Arbor, MI. | Health Technology |
